Form 4: Amedisys EVP, CFO & COO Scott Ginn Reports Stock Disposal

Sentiment:

SEC Form 4


Scott Ginn, EVP, CFO & COO of Amedisys Inc., reports the disposal of 2,430 shares of common stock to cover tax obligations.

Summary

  • On February 20, 2025, Scott Ginn, the EVP, CFO & COO of Amedisys Inc., disposed of 2,430 shares of common stock.
  • The transaction was executed at a price of $91.09 per share.
  • This disposal was likely to cover tax obligations related to vesting equity.
  • Following the transaction, Ginn directly owns 94,056 shares of Amedisys Inc.
  • Ginn also indirectly owns 2,714 shares through a 401(k) plan, based on a statement dated December 31, 2024.
  • The total amount of shares beneficially owned includes 887 shares held in an employee stock purchase plan account.

Sentiment

Score: 5

Explanation: This is a neutral filing. It simply reports a stock disposal, likely for tax purposes, and doesn't inherently indicate positive or negative sentiment about the company's future.

Industry Context

Form 4 filings are a routine part of executive compensation and provide transparency into insider transactions. They are closely watched by investors for signals about a company's prospects, although this particular filing appears to be a routine transaction to cover tax obligations.

Key Dates

DateDescription
2024/12/31Date of 401(k) plan statement.
2025/02/20Date of stock disposal transaction.
2025/02/24Date of signature on the report.

Keywords

Amedisys, Scott Ginn, Stock Disposal, Form 4, Insider Trading, AMED, Executive Compensation, Securities Exchange Act

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.